The trial is seen as a complement to the MAIA trial, which had shown a significant overall survival benefit with daratumumab ...

The agency is considering whether to limit the indications of Keytruda, Opdivo, and Tevimbra to PD-L1-positive patients amid testing uncertainties.

By way of two resoundingly consistent votes, members of an FDA advisory committee agreed that PD-1 inhibitors do not have a favorable risk/benefit profile for gastroesophageal cancers with low PD-L1 ...

More than 1,600 children from throughout the United States have received a jacket or tote. Doctors say such programs bolster ...

A study by Princeton Hydro is providing greater detail into what led up to the harmful algal blooms that rocked Smith Mountain Lake last summer.

While the stats are nice, Lemn likes his team’s mental approach these last few weeks, especially coming off the season ...